RA Robson

1.2k total citations
27 papers, 955 citations indexed

About

RA Robson is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, RA Robson has authored 27 papers receiving a total of 955 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 9 papers in Pediatrics, Perinatology and Child Health and 7 papers in Pharmacology. Recurrent topics in RA Robson's work include Pharmacogenetics and Drug Metabolism (9 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). RA Robson is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). RA Robson collaborates with scholars based in New Zealand, Australia and Netherlands. RA Robson's co-authors include John O. Miners, DJ Birkett, Aznan Lelo, D. J. Birkett, R. K. Penhall, AG Whitehead, Michael E. McManus, EJ Begg, Joanna Stewart and W A A G Macbeth and has published in prestigious journals such as British journal of surgery, Journal of Antimicrobial Chemotherapy and British Journal of Clinical Pharmacology.

In The Last Decade

RA Robson

27 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
RA Robson New Zealand 17 343 248 196 184 138 27 955
Barbara Ameer United States 20 547 1.6× 270 1.1× 216 1.1× 238 1.3× 160 1.2× 42 1.9k
A Breckenridge United Kingdom 17 326 1.0× 92 0.4× 189 1.0× 123 0.7× 242 1.8× 57 1.1k
Stephen D. Wise Singapore 16 244 0.7× 207 0.8× 104 0.5× 101 0.5× 163 1.2× 29 985
S. Harder Germany 20 133 0.4× 237 1.0× 203 1.0× 158 0.9× 197 1.4× 73 1.2k
E. Jähnchen Germany 22 413 1.2× 244 1.0× 134 0.7× 156 0.8× 453 3.3× 91 1.5k
Mark J. Goldberg United States 21 345 1.0× 346 1.4× 172 0.9× 111 0.6× 332 2.4× 49 1.6k
Ingegerd Odar‐Cederlöf Sweden 23 293 0.9× 256 1.0× 390 2.0× 218 1.2× 195 1.4× 53 1.7k
Adithan Chandrasekaran India 20 383 1.1× 148 0.6× 134 0.7× 221 1.2× 204 1.5× 73 1.2k
Victoria Rollason Switzerland 18 363 1.1× 176 0.7× 205 1.0× 203 1.1× 149 1.1× 50 1.3k
Alberto M. Borobia Spain 22 388 1.1× 241 1.0× 260 1.3× 178 1.0× 92 0.7× 104 1.5k

Countries citing papers authored by RA Robson

Since Specialization
Citations

This map shows the geographic impact of RA Robson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RA Robson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RA Robson more than expected).

Fields of papers citing papers by RA Robson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RA Robson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RA Robson. The network helps show where RA Robson may publish in the future.

Co-authorship network of co-authors of RA Robson

This figure shows the co-authorship network connecting the top 25 collaborators of RA Robson. A scholar is included among the top collaborators of RA Robson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RA Robson. RA Robson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Begg, EJ, RA Robson, Sharon J. Gardiner, et al.. (2001). Quinapril and its metabolite quinaprilat in human milk. British Journal of Clinical Pharmacology. 51(5). 478–481. 16 indexed citations
2.
Bailey, Ross R., Brett Shand, Andrew H. Smith, RA Robson, & K L Lynn. (1997). Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.. PubMed. 48(4). 224–9. 3 indexed citations
3.
Robson, RA. (1992). Quinolone pharmacokinetics. International Journal of Antimicrobial Agents. 2(1). 3–10. 22 indexed citations
4.
Robson, RA, et al.. (1992). The effect of celiprolol on glomerular filtration rate and renal blood flow in patients with chronic renal impairment and healthy volunteers.. British Journal of Clinical Pharmacology. 33(4). 454–457. 3 indexed citations
5.
Chambers, Stephen T., et al.. (1991). Antimicrobial effects of lomefloxacin in vitro. Journal of Antimicrobial Chemotherapy. 27(4). 481–489. 8 indexed citations
6.
McGregor, Alistair, et al.. (1990). Disseminated prostatic carcinoma presenting with acute interstitial nephritis and microangiopathic haemolytic anaemia. Australian and New Zealand Journal of Medicine. 20(2). 170–172. 3 indexed citations
7.
Begg, EJ, et al.. (1990). The pharmacokinetics and pharmacodynamics of quinapril and quinaprilat in renal impairment.. British Journal of Clinical Pharmacology. 30(2). 213–220. 27 indexed citations
8.
Robson, RA, et al.. (1990). Comparative effects of ciprofloxacin and lomefloxacin on the oxidative metabolism of theophylline.. British Journal of Clinical Pharmacology. 29(4). 491–493. 31 indexed citations
9.
Begg, EJ, et al.. (1989). The pharmacokinetics of angiotensin converting enzyme inhibitors in patients with renal impairment.. PubMed. 7(5). S29–32. 18 indexed citations
10.
Miners, John O., R. K. Penhall, RA Robson, & D. J. Birkett. (1988). Comparison of paracetamol metabolism in young adult and elderly males. European Journal of Clinical Pharmacology. 35(2). 157–160. 64 indexed citations
11.
Robson, RA, et al.. (1988). Cyclosporin‐verapamil interaction.. British Journal of Clinical Pharmacology. 25(3). 402–403. 25 indexed citations
12.
Robson, RA, John O. Miners, & DJ Birkett. (1988). Selective inhibitory effects of nifedipine and verapamil on oxidative metabolism: effects on theophylline.. British Journal of Clinical Pharmacology. 25(3). 397–400. 17 indexed citations
13.
Robson, RA, et al.. (1987). Characterisation of theophylline metabolism in human liver microsomes.. British Journal of Clinical Pharmacology. 24(3). 293–300. 98 indexed citations
14.
Lelo, Aznan, John O. Miners, RA Robson, & DJ Birkett. (1986). Quantitative assessment of caffeine partial clearances in man.. British Journal of Clinical Pharmacology. 22(2). 183–186. 104 indexed citations
15.
Lelo, Aznan, DJ Birkett, RA Robson, & John O. Miners. (1986). Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man.. British Journal of Clinical Pharmacology. 22(2). 177–182. 140 indexed citations
16.
Miners, John O., RA Robson, & DJ Birkett. (1986). Paracetamol metabolism in pregnancy.. British Journal of Clinical Pharmacology. 22(3). 359–362. 70 indexed citations
17.
Miners, John O., et al.. (1986). Influence of gender and oral contraceptive steroids on the metabolism of salicylic acid and acetylsalicylic acid.. British Journal of Clinical Pharmacology. 22(2). 135–142. 61 indexed citations
18.
Tapson, J.S., J. P. Owen, RA Robson, et al.. (1985). Compensatory renal hypertrophy after donor nephrectomy. Clinical Radiology. 36(3). 307–310. 17 indexed citations
19.
Robson, RA, et al.. (1984). Theophylline‐rifampicin interaction: non‐selective induction of theophylline metabolic pathways.. British Journal of Clinical Pharmacology. 18(3). 445–448. 29 indexed citations
20.
Stewart, Richard J., RA Robson, Alistair W. Stewart, Joanna Stewart, & W A A G Macbeth. (1979). Cancer of the large bowel in a defined population: Canterbury, New Zealand, 1970–4. British journal of surgery. 66(5). 309–314. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Ameer Breakdown of academic impact, for papers by A Breckenridge Breakdown of academic impact, for papers by Stephen D. Wise Breakdown of academic impact, for papers by S. Harder Breakdown of academic impact, for papers by E. Jähnchen Breakdown of academic impact, for papers by Mark J. Goldberg Breakdown of academic impact, for papers by Ingegerd Odar‐Cederlöf Breakdown of academic impact, for papers by Adithan Chandrasekaran Breakdown of academic impact, for papers by Victoria Rollason Breakdown of academic impact, for papers by Alberto M. Borobia
Rankless by CCL
2026